Archive explorer

Browse & search snapshots

Important note

Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.

For background on coverage and capture methods, see Methods & coverage.

Browse archived sites

Browse all sources →

Non-prescription Drug Action Plan - Canada.ca

Health CanadaCaptures 88Latest capture Apr 11, 2026en

Non-prescription Drug Action Plan On this page About the action plan Policy and operational approach About the action plan Health Canada is committed to simplifying market access for non-prescription drugs. As a first step, we developed the Non-prescription Drug Action Plan. This…

Health Canada: The Food and Consumer Safety Action Plan Your family's safety. Our government's priority. From groceries to prescription drugs and children's toys, you want to know that the food, health and consumer products you use every day are safe. The Government of Canada…

Concerns about children's medication - Canada.ca

Health CanadaCaptures 93Latest capture Apr 11, 2026en

Concerns about children's medication Avoiding cough and cold medications Because of the ingredients they contain, non-prescription cough and cold medicines should never be given to children under the age of six. Always check the label first to make sure the medication is suitable…

Summary Basis of Decision (SBD) - Canada.ca

Health CanadaCaptures 87Latest capture Apr 11, 2026en

Summary Basis of Decision (SBD) Contact: Office of Planning, Performance and Review Services Summary Basis of Decision (SBD) documents explain why Health Canada authorized certain drugs and medical devices for sale in Canada. The documents include regulatory, safety,…

Regulatory Decision Summaries - Canada.ca

Health CanadaCaptures 97Latest capture Apr 11, 2026en

Regulatory Decision Summaries Regulatory Decision Summaries (RDSs) explain Health Canada's decision for certain health products seeking market authorization. The RDSs include the purpose of the submission and the reason for the decision. These pages also include summaries of…

Drug and Health Product Submissions Under Review (SUR): Overview Overview New drug submissions under review Supplemental submissions under review New drug submissions completed Supplemental submissions completed Notice to stakeholders As of March 20, 2026: The lists of…

Certificates of Supplementary Protection (CSP) and Applications The Office of Patented Medicines and Liaison (OPML) should be contacted in advance of a CSP application filing deadline in order to obtain a CSP Customer Number or to confirm an existing CSP Customer Number, if it is…

Advisories and Recalls – MedEffect Canada If you are currently suffering from an adverse reaction to drugs or health products, contact your health professional or local health authorities. The Recalls and Safety Alerts Database provides easy access to a comprehensive list of…

Page 2337 of 3977Showing 23361-23370 of 39762

Early release: coverage and features are still expanding.